T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.58B |
| 2 |
T-Mobile US
TMUS
|
+$1.53B |
| 3 |
Morgan Stanley
MS
|
+$1.15B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.15B |
| 5 |
Apple
AAPL
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$2.94B |
| 2 |
Amazon
AMZN
|
+$2.82B |
| 3 |
GE Aerospace
GE
|
+$1.93B |
| 4 |
Goldman Sachs
GS
|
+$1.88B |
| 5 |
ServiceNow
NOW
|
+$1.28B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.25% |
| 2 | Healthcare | 17.75% |
| 3 | Financials | 11.32% |
| 4 | Consumer Discretionary | 11.17% |
| 5 | Communication Services | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Chegg
CHGG
$91.4M
| $956K | ﹤0.01% |
58,610
+7,714
| +15% | +$144K |
|
1802
MYR Group
MYRG
$5.17B
| $956K | ﹤0.01% |
7,579
+2,897
| +62% | +$312K |
|
1803
CryoPort
CYRX
$763M
| $955K | ﹤0.01% |
39,781
+1,272
| +3% | +$27.7K |
|
1804
WaFd
WAFD
$2.83B
| $954K | ﹤0.01% |
31,657
+1,175
| +4% | +$39.7K |
|
|
B
1805
DELISTED
Barnes Group Inc.
B
| $952K | ﹤0.01% |
23,614
+892
| +4% | +$37.5K |
|
|
CIM
1806
Chimera Investment
CIM
$1,000M
| $949K | ﹤0.01% |
56,053
+6,127
| +12% | +$117K |
|
1807
Myriad Genetics
MYGN
$298M
| $947K | ﹤0.01% |
40,734
+1,163
| +3% | +$23.6K |
|
1808
Moelis & Co
MC
$5.16B
| $945K | ﹤0.01% |
24,578
+1,066
| +5% | +$45.8K |
|
1809
Compass Minerals
CMP
$1.11B
| $944K | ﹤0.01% |
27,514
+1,148
| +4% | +$45.9K |
|
1810
Methode Electronics
MEI
$593M
| $944K | ﹤0.01% |
21,502
+431
| +2% | +$20K |
|
1811
Provident Financial Services
PFS
$3.24B
| $941K | ﹤0.01% |
49,028
+1,296
| +3% | +$28.7K |
|
1812
Astrana Health
ASTH
$1.91B
| $941K | ﹤0.01% |
25,795
+968
| +4% | +$33.9K |
|
1813
Shake Shack
SHAK
$3.01B
| $938K | ﹤0.01% |
16,890
+651
| +4% | +$35.9K |
|
1814
Beam Therapeutics
BEAM
$2.67B
| $937K | ﹤0.01% |
30,569
+971
| +3% | +$38.3K |
|
|
EQC
1815
DELISTED
Equity Commonwealth
EQC
| $936K | ﹤0.01% |
45,151
-2,095,431
| -98% | -$48.6M |
|
1816
Trustmark
TRMK
$2.82B
| $934K | ﹤0.01% |
37,795
+1,130
| +3% | +$33.4K |
|
1817
Hanmi Financial
HAFC
$968M
| $932K | ﹤0.01% |
50,090
+7,312
| +17% | +$166K |
|
1818
NETSCOUT
NTCT
$2.89B
| $932K | ﹤0.01% |
32,508
+1,787
| +6% | +$53.5K |
|
|
NXGN
1819
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $927K | ﹤0.01% |
53,216
+548
| +1% | +$9.85K |
|
1820
Apogee Enterprises
APOG
$886M
| $926K | ﹤0.01% |
21,398
+2,695
| +14% | +$121K |
|
1821
Greif
GEF
$4.98B
| $925K | ﹤0.01% |
14,595
+463
| +3% | +$31K |
|
1822
Northwest Natural Holdings
NWN
$2.14B
| $917K | ﹤0.01% |
19,261
-1,874
| -9% | -$90.6K |
|
1823
BridgeBio Pharma
BBIO
$15.5B
| $916K | ﹤0.01% |
55,201
-11,321
| -17% | -$132K |
|
1824
Nu Skin
NUS
$237M
| $916K | ﹤0.01% |
23,286
-779
| -3% | -$32.4K |
|
1825
Cohen & Steers
CNS
$4.37B
| $914K | ﹤0.01% |
14,275
+434
| +3% | +$30.3K |
|
Similar funds
T. Rowe Price Associates's Q1 2023 Portfolio in Review
As of Q1 2023, T. Rowe Price Associates held 3,020 positions worth $668B, up 7.5% from $622B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2023 filing shows 65 new, 1,711 increased, 924 reduced and 98 closed positions. Its largest new stake was Suncor Energy: 6,437,236 shares worth $200M. The largest sale was Alphabet (Google) Class C, an estimated $2.94B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2023 buy was Suncor Energy: 6,437,236 shares worth $200M.
- T. Rowe Price Associates added most to Tesla in Q1 2023, an estimated $1.58B increase.
- T. Rowe Price Associates's biggest Q1 2023 reduction was Alphabet (Google) Class C, cutting an estimated $2.94B.
- T. Rowe Price Associates fully exited Signature Bank in Q1 2023, selling an estimated $360M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $668B portfolio in Q1 2023.
- T. Rowe Price Associates opened 65 new positions and closed 98 in Q1 2023.
- T. Rowe Price Associates's portfolio value rose 7.5% quarter-over-quarter to $668B.
Based on T. Rowe Price Associates's 13F filing for Q1 2023, filed 15 May 2023.